Skip to main content

USANA Health Sciences Reports Third Quarter 2025 Results and Updates Full-Year Outlook

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended September 27, 2025.

Key Financial Results

Third Quarter 2025 vs. Third Quarter 2024

  • Net sales of $214 million versus $200 million, representing 7% year-over-year growth.
  • Net loss of -$6.5 million versus net earnings of $10.6 million.
  • Diluted EPS of -$0.36 as compared with $0.56.
  • Adjusted diluted EPS(1) of -$0.15 as compared with $0.56.
  • Adjusted EBITDA(2) of $13.8 million versus $24.6 million.
  • Direct selling Active Customers of 388,000 versus 452,000.
  • Hiya Active Monthly Subscribers of 193,400.

Q3 2025 Financial Performance

Consolidated Results

 

Year-Over-Year

Sequentially

Net Sales

$214 million

+7% (No meaningful FX impact)

-9%

Net (Loss) Earnings*

-$6.5 million

N/A

N/A

Diluted EPS

-$0.36

N/A

N/A

Adjusted Diluted EPS(1)

-$0.15

N/A

N/A

Adjusted EBITDA(2)

$13.8 million

-44%

-55%

*Pretax earnings for Q3 2025 totaled $1.8 million with income tax expense of $8.5 million. The adjustment to income taxes during the period, as a result of updating the annual effective tax rate, is about $7.6 million greater than what would have been expected using the previously guided 45% tax rate.

Net earnings, EPS and EBITDA figures represent amounts attributable to USANA and excludes the noncontrolling interest of 21.15% in Hiya.

“USANA provided third quarter results in line with the preliminary results we announced on October 9, 2025,” said Jim Brown, President and Chief Executive Officer. “We rolled out our enhanced Brand Partner compensation plan during the third quarter. Since this launch, our commercial team has been actively training, educating and supporting Brand Partners across our global markets to help them leverage the new plan. We are encouraged by the pickup in sales activity and leader productivity in recent weeks. Our enhanced compensation plan represents a bold and strategic move to modernize our business and better position our Brand Partners, and the Company, for long-term success in a competitive landscape.

“We held a successful Global Convention in Salt Lake City during the third quarter where we launched several new and upgraded products, recognized our Brand Partners, and trained them on our enhanced compensation plan. Our commercial team will continue to work alongside our Brand Partners over the next several quarters to help promote our new products and compensation plan. We remain confident that our product and opportunity strategy will position the Company to drive growth in our direct selling business and deliver long-term value for our stakeholders.

“Hiya, our direct-to-consumer (DTC) business, has delivered 26% year-to-date sales growth, and made significant progress on several integration initiatives during the quarter, including the transition to a new logistics partner, which is anticipated to drive operational efficiency. We are also leveraging USANA’s manufacturing expertise to support Hiya and will begin bringing their products in-house over the next several months. We continue to expect Hiya to generate double-digit sales growth for 2025 and remain confident in their long-term growth.”

Q3 2025 Direct Selling Regional Results:

Asia Pacific Region

 

Year-Over-Year

Year-Over-Year

(Constant Currency)

Sequentially

Net Sales

$140 million

-13%

-13%

-15%

Active Customers

308,000

-14%

N/A

-8%

Asia Pacific Sub-Regions

 

 

Year-Over-Year

Year-Over-Year

(Constant Currency)

Sequentially

Greater China

Net Sales

$93 million

-9%

No meaningful FX impact

-18%

Active

210,000

-14%

N/A

-9%

Customers

North Asia

Net Sales

$18 million

-14%

-12%

+3%

Active

37,000

-10%

N/A

—%

Customers

Southeast Asia Pacific

Net Sales

$29 million

-22%

-23%

-11%

Active

61,000

-20%

N/A

-10%

Customers

Americas and Europe Region

 

 

Year-Over-Year

Year-Over-Year

(Constant Currency)

Sequentially

Net Sales*

$43 million

+8%

+8%

+12%

Active Customers

80,000

-13%

N/A

-2%

*Includes $7 million of ‘Other’

Q3 2025 Hiya Direct to Consumer Results:

Hiya

Net Sales

$31 million

Active Monthly Subscribers

193,400

Balance Sheet

The Company ended the quarter with $145 million in cash and cash equivalents and no debt. The Company has approximately $34 million remaining under the current share repurchase authorization as of the end of the third quarter.

Fiscal Year 2025 Outlook

The Company is updating its outlook for fiscal year 2025, as follows:

Fiscal Year 2025 Outlook

 

Updated Estimate

Previous Range

Consolidated net sales

$920 million

$920 million to $1.0 billion

Net earnings

$15 million

$29 million to $41 million

Diluted EPS

$0.78

$1.50 to $2.20

Adjusted Diluted EPS(1)

$1.73

$2.35 to $3.00

Adjusted EBITDA(2)

$98 million

$107 million to $123 million

Net earnings, EPS and EBITDA figures represent amounts attributable to USANA and excludes the noncontrolling interest of 21.15% in Hiya.

Doug Hekking, Chief Financial Officer, commented, “Short-term profitability was burdened during the third quarter due to softer than anticipated sales, meaningful investments to support the roll out of our enhanced Brand Partner compensation plan, and a change in the estimated annual effective income tax rate that disproportionately impacted the current year quarter. Specifically, lower than expected earnings coupled with the concentration of operating and administrative expenses in the United States resulted in a meaningful increase in the annualized effective income tax rate in the third quarter from 45% to 65%. The adjustment was approximately $7.6 million greater than what would have been expected using the previously guided 45% tax rate.

“Our revised outlook reflects modest sequential improvement in both our direct sales and DTC businesses, albeit from a lower customer base as a result of third quarter performance. We have initiated and are executing a comprehensive process to align all costs throughout the business globally with our current level of sales. As a result of this realignment and rightsizing process, we expect to incur an estimated one-time charge of $4.7 million in the fourth quarter, which is reflected in our updated outlook. We will provide an update on this process, including the actual charge, when we report our fourth quarter and full-year results early next year.”

The Company’s fiscal 2025 outlook reflects:

  • Net sales from the direct selling business of approximately $788 million;
  • Net sales from Hiya of approximately $132 million, reflecting year-over-year growth of 16%;
  • Fiscal 2025 is a 53-week year and includes one additional week of sales compared to fiscal 2024. Prior to 2025, the last 53-week year was in fiscal 2020.

____________________

(1) Adjusted Diluted Earnings Per Share is a non-GAAP financial measure. The Company excludes acquisition-related costs, such as business transaction costs, integration expense and amortization expense from acquisition related intangible assets in calculating Adjusted Diluted Earnings Per Share. Please refer to “Non-GAAP Financial Measures” and “Reconciliation of Diluted (Loss) Earnings Per Share (GAAP) to Adjusted Diluted (Loss) Earnings Per Share (Non-GAAP)” in this press release for an explanation and reconciliation of this non-GAAP financial measure.

(2) Adjusted EBITDA is a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” and “Reconciliation of Net (Loss) Earnings (GAAP) to Adjusted EBITDA (Non-GAAP)” in this press release for an explanation and reconciliation of this non-GAAP financial measure.

Non-GAAP Financial Measures

This press release contains the non-GAAP financial measures Adjusted EBITDA and Adjusted diluted EPS. Adjusted EBITDA is a Non-GAAP financial measure of earnings before interest, taxes, depreciation, and amortization that also excludes certain adjustments as indicated below in the reconciliation from net earnings. Adjusted diluted EPS is a Non-GAAP financial measure of diluted earnings per share that excludes certain adjustments as indicated below in the reconciliation from diluted EPS.

Adjusted EBITDA (non-GAAP) is net earnings (loss) (its most directly comparable GAAP financial measure) adjusted for interest expense, net, (benefit from) provision for income taxes, depreciation and amortization, non-cash share-based compensation, and transaction-related expenses and integration costs for the Hiya acquisition. Adjusted EBITDA attributable to USANA (non-GAAP) is Adjusted EBITDA (non-GAAP) further adjusted to exclude the Adjusted EBITDA attributable to non-controlling interest related to Hiya.

Adjusted diluted earnings per share (non-GAAP) is diluted earnings (loss) per share (its most directly comparable GAAP financial measure) adjusted for amortization of intangible assets, transaction-related expenses, and integration costs related to the Hiya acquisition.

Management believes that Adjusted EBITDA (non-GAAP), Adjusted EBITDA attributable to USANA (non-GAAP), and Adjusted diluted earnings per share (non-GAAP), along with GAAP measures used by management, most appropriately reflect how the Company measures the business internally.

The Company prepares its financial statements using U.S. generally accepted accounting principles (“GAAP”) and investors should not directly compare with or infer relationship from any of the Company’s operating results presented in accordance with GAAP to Adjusted EBITDA and Adjusted diluted earnings per share. Non-GAAP financial measures have limitations in their usefulness to investors because they have no standardized meaning prescribed by GAAP and are not prepared under any comprehensive set of accounting rules or principles. In addition, other companies, including companies in our industry, may calculate similarly titled non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of non-GAAP financial information as a tool for comparison. As a result, the non-GAAP financial information is presented for supplemental informational purposes only and should not be considered in isolation from, or as a substitute for financial information presented in accordance with GAAP.

Reconciliation of Net (Loss) Earnings (GAAP) to Adjusted EBITDA (non-GAAP)

(in thousands)

 

 

 

Quarter Ended

 

Nine months ended

 

 

September 27, 2025

 

September 28, 2024

 

September 27, 2025

 

September 28, 2024

 

 

 

 

 

 

 

 

 

Net earnings (loss) attributable to USANA (GAAP)

 

$

(6,522

)

 

$

10,607

 

 

$

12,535

 

 

$

37,576

 

Net earnings (loss) attributable to noncontrolling interest

 

 

(140

)

 

 

 

 

 

537

 

 

 

 

Net earnings (loss)

 

$

(6,662

)

 

$

10,607

 

 

$

13,072

 

 

$

37,576

 

 

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

 

 

Income taxes

 

$

8,456

 

 

$

8,001

 

 

$

24,278

 

 

$

28,346

 

Interest (income) expense

 

 

(529

)

 

 

(3,093

)

 

 

(1,201

)

 

 

(8,429

)

Depreciation and amortization

 

 

5,112

 

 

 

5,559

 

 

 

16,050

 

 

 

16,345

 

Amortization of intangible assets - Hiya

 

 

4,455

 

 

 

 

 

 

13,366

 

 

 

 

Earnings before interest, taxes, depreciation, and amortization (EBITDA)

 

$

10,832

 

 

$

21,074

 

 

$

65,565

 

 

$

73,838

 

 

 

 

 

 

 

 

 

 

Add EBITDA adjustments:

 

 

 

 

 

 

 

 

Non-cash share-based compensation

 

 

3,576

 

 

 

3,542

 

 

 

10,078

 

 

 

10,945

 

Transaction, integration and transition costs - Hiya

 

 

179

 

 

 

 

 

 

871

 

 

 

 

Inventory step-up - Hiya

 

 

 

 

 

 

 

 

1,126

 

 

 

 

Consolidated adjusted EBITDA

 

 

14,587

 

 

 

24,616

 

 

 

77,640

 

 

 

84,783

 

Less: Adjusted EBITDA attributable to noncontrolling interest

 

 

(804

)

 

 

 

 

 

(3,604

)

 

 

 

Adjusted EBITDA attributable to USANA

 

$

13,783

 

 

$

24,616

 

 

$

74,036

 

 

$

84,783

 

 

Reconciliation of Diluted (Loss) Earnings Per Share (GAAP) to Adjusted Diluted (Loss) Earnings Per Share (non-GAAP)

(in thousands, except per share data)

 

 

 

Quarter Ended

 

Nine months ended

 

 

September 27, 2025

 

September 28, 2024

 

September 27, 2025

 

September 28, 2024

Net earnings (loss) attributable to USANA (GAAP)

 

$

(6,522

)

 

$

10,607

 

$

12,535

 

 

$

37,576

 

 

 

 

 

 

 

 

 

Earnings (loss) per common share - Diluted (GAAP)

 

$

(0.36

)

 

$

0.56

 

$

0.67

 

 

$

1.96

Weighted Average common shares outstanding - Diluted

 

 

18,293

 

 

 

19,083

 

 

18,671

 

 

 

19,181

 

 

 

 

 

 

 

 

 

Adjustment to net earnings (loss):

 

 

 

 

 

 

 

 

Transaction, integration and transition costs - Hiya

 

$

179

 

 

$

 

$

871

 

 

$

Inventory step-up - Hiya

 

 

 

 

 

 

 

1,126

 

 

 

Amortization of intangible assets - Hiya

 

 

4,455

 

 

 

 

 

13,366

 

 

 

Adjustments to net earnings (loss) attributable to noncontrolling interest

 

 

(941

)

 

 

 

 

(3,066

)

 

 

Income tax effect of adjustments to net earnings (loss)

 

 

 

 

 

 

 

(4

)

 

 

Adjusted net earnings (loss) attributable to USANA

 

$

(2,829

)

 

$

10,607

 

$

24,828

 

 

$

37,576

 

 

 

 

 

 

 

 

 

Adjusted earnings (loss) per common share - Diluted

 

$

(0.15

)

 

$

0.56

 

$

1.33

 

 

$

1.96

Weighted average common shares outstanding - Diluted

 

 

18,293

 

 

 

19,083

 

 

18,671

 

 

 

19,181

 

Management Commentary Document and Conference Call

For further information on the USANA’s operating results, please see the Management Commentary document, which has been posted on the Company’s website (http://ir.usana.com) under the Investor Relations section. USANA’s management team will hold a conference call and webcast to discuss today’s announcement with investors on Thursday, October 23, 2025 at 11:00 AM Eastern Time. Investors may listen to the call by accessing USANA’s website at http://ir.usana.com. The call will consist of brief opening remarks by the Company’s management team, followed by a questions and answers session.

Safe Harbor

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. These forward-looking statements are based on current plans, expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management. Words such as “expect,” “enhance,” “drive,” “anticipate,” “intend,” “improve,” “promote,” “should,” “believe,” “continue,” “plan,” “goal,” “opportunity,” “estimate,” “predict,” “may,” “will,” “could,” and “would,” and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Such forward-looking statements include, but are not limited to, statements regarding Hiya’s growth in 2025 and continued growth in the future; statements about the Company’s long-term growth; and the statements under the sub-heading “Fiscal Year 2025 Outlook.” Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control, including: risks relating to global economic conditions generally, including continued inflationary pressure around the world and negative impact on our operating costs, consumer demand and consumer behavior in general; reliance upon our network of independent Brand Partners; risk that our Brand Partner compensation plan, or changes that we make to the compensation plan, will not produce desired results, benefit our business or, in some cases, could harm our business; risk associated with our launch of new products or reformulated existing products; risks related to governmental regulation of our products, manufacturing and direct selling business model in the United States, China and other key markets; potential negative effects of deteriorating foreign and/or trade relations between or among the United States, China and other key markets, including potential adverse impact from tariffs, trade policies or other international disputes by and among the United States, China, or other markets that are important to the Company; potential negative effects from geopolitical relations and conflicts around the world, including the Russia-Ukraine conflict and the conflict in Israel; compliance with data privacy and security laws and regulations in our markets around the world; potential negative effects of material breaches of our information technology systems to the extent we experience a material breach; material failures of our information technology systems; adverse publicity risks globally; risks associated with early stage operations in India and future international expansion and operations; uncertainty relating to the fluctuation in U.S. and other international currencies; the potential for a resurgence of COVID-19, or another pandemic, in any of our markets in the future and any related impact on consumer health, domestic and world economies, including any negative impact on discretionary spending, consumer demand, and consumer behavior in general; risk that the Hiya acquisition disrupts each company’s current plans and operations; the diversion of the attention of the management teams of USANA and Hiya from ongoing business operations; the ability of to retain key personnel of Hiya; the ability to realize the benefits of the acquisition, including efficiencies and cost synergies; the ability to successfully integrate Hiya’s business with USANA’s business, at all or in a timely manner; and the amount of the costs, fees, expenses and charges related to the acquisition. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission. The forward-looking statements in this press release set forth our beliefs as of the date hereof. We do not undertake any obligation to update any forward-looking statement after the date hereof or to conform such statements to actual results or changes in the Company’s expectations, except as required by law.

About USANA

USANA develops and manufactures high-quality nutritional supplements, functional foods and personal care products that are sold directly to Brand Partners and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, China, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France, Belgium, Colombia, Indonesia, Germany, Spain, Romania, Italy, and India. More information on USANA can be found at www.usana.com. USANA also owns a 78.8% controlling ownership stake in Hiya Health Products, a children's health and wellness company with a variety of clean-label products. More information on Hiya can be found at www.hiyahealth.com.

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

 

Three Months Ended

 

 

September 27,

2025

 

September 28,

2024

 

Net sales

$

213,670

 

 

$

200,221

 

 

Cost of sales

 

48,815

 

 

 

39,257

 

 

Gross profit

 

164,855

 

 

 

160,964

 

 

Operating expenses:

 

 

 

 

Brand Partner incentives

 

77,684

 

 

 

84,068

 

 

Selling, general and administrative

 

85,947

 

 

 

61,295

 

 

Total operating expenses

 

163,631

 

 

 

145,363

 

 

Earnings from operations

 

1,224

 

 

 

15,601

 

 

Other income (expense):

 

 

 

 

Interest income

 

578

 

 

 

3,142

 

 

Interest expense

 

(49

)

 

 

(49

)

 

Other, net

 

41

 

 

 

(86

)

 

Other income (expense), net

 

570

 

 

 

3,007

 

 

Earnings before income taxes

 

1,794

 

 

 

18,608

 

 

Income taxes

 

8,456

 

 

 

8,001

 

 

Net (loss) earnings

 

(6,662

)

 

 

10,607

 

 

Less: Net (loss) earnings attributable to redeemable noncontrolling interest

 

(140

)

 

 

 

 

Net (loss) earnings attributable to USANA

$

(6,522

)

 

$

10,607

 

 

 

 

 

 

 

(Loss) earnings per common share attributable to USANA

 

 

 

 

Basic

$

(0.36

)

 

$

0.56

 

 

Diluted

$

(0.36

)

 

$

0.56

 

 

 

 

 

 

 

Weighted average common shares outstanding

 

 

 

 

Basic

 

18,293

 

 

 

19,078

 

 

Diluted

 

18,293

 

 

 

19,083

 

 

 

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

 

 

As of

September 27,

2025

 

As of

December 28,

2024

ASSETS

 

 

 

Current assets

 

 

 

Cash and cash equivalents

$

145,349

 

$

181,768

Inventories

 

90,781

 

 

69,735

Prepaid expenses and other current assets

 

27,935

 

 

27,684

Total current assets

 

264,065

 

 

279,187

Property and equipment, net

 

96,212

 

 

94,565

Goodwill

 

144,288

 

 

144,168

Intangible assets, net

 

138,159

 

 

151,823

Deferred tax assets

 

24,157

 

 

19,644

Other assets*

 

59,710

 

 

58,806

Total assets

$

726,591

 

$

748,193

 

 

 

 

LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST, AND STOCKHOLDERS' EQUITY

 

 

 

Current liabilities

 

 

 

Accounts payable

$

17,095

 

$

11,984

Line of credit

 

 

 

23,000

Other current liabilities

 

101,569

 

 

104,641

Total current liabilities

 

118,664

 

 

139,625

Deferred tax liabilities

 

4,467

 

 

4,073

Other long-term liabilities

 

21,907

 

 

18,163

 

 

 

 

Redeemable noncontrolling interest

 

53,479

 

 

54,223

 

 

 

 

Total stockholders' equity attributable to USANA

 

528,074

 

 

532,109

Total liabilities, redeemable noncontrolling interest, and stockholders' equity

$

726,591

 

$

748,193

 

*Includes noncurrent inventories of $2,802 and $2,688 as of 27-Sep-25 and 28-Dec-24, respectively. Total inventories were $93,583 and $72,423 as of 27-Sep-25 and 28-Dec-24, respectively.

 

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

SALES BY REGION

(in thousands)

(unaudited)

 

 

Quarter Ended

 

 

 

 

 

September 27,

2025

 

September 28,

2024

 

Change from

prior
year

 

Percent

change

 

Currency impact

on sales

 

Percent

change

excluding

currency

impact

Direct Selling:

 

 

 

 

 

 

 

 

Asia Pacific

 

 

 

 

 

 

 

 

Greater China

$

92,571

43.3

%

$

102,261

51.1

%

$

(9,690

)

(9.5

%)

$

504

 

(10.0

%)

Southeast Asia Pacific

 

29,178

13.7

%

 

37,267

18.6

%

 

(8,089

)

(21.7

%)

 

393

 

(22.8

%)

North Asia

 

17,690

8.3

%

 

20,541

10.2

%

 

(2,851

)

(13.9

%)

 

(403

)

(11.9

%)

Asia Pacific total

 

139,439

65.3

%

 

160,069

79.9

%

 

(20,630

)

(12.9

%)

 

494

 

(13.2

%)

Americas and Europe

 

36,386

17.0

%

 

38,398

19.2

%

 

(2,012

)

(5.2

%)

 

72

 

(5.4

%)

Direct Selling total

 

175,825

82.3

%

 

198,467

99.1

%

 

(22,642

)

(11.4

%)

 

566

 

(11.7

%)

Hiya

 

30,846

14.4

%

 

%

 

30,846

 

N/A

 

 

 

N/A

 

Other

 

6,999

3.3

%

 

1,754

0.9

%

 

5,245

 

299.0

%

 

 

299.0

%

Consolidated total

$

213,670

100.0

%

$

200,221

100.0

%

$

13,449

 

6.7

%

$

566

 

6.4

%

 

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

DIRECT SELLING ACTIVE BRAND PARTNERS AND ACTIVE PREFERRED CUSTOMERS BY REGION

(unaudited)

 

Direct Selling Active Brand Partners by Region(1)

 

(unaudited)

 

 

As of

September 27, 2025

 

As of

September 28, 2024

Asia Pacific

 

 

 

 

 

 

 

 

Greater China

 

61,000

 

36.3 %

 

65,000

 

34.6 %

Southeast Asia Pacific

 

43,000

 

25.6 %

 

52,000

 

27.6 %

North Asia

 

27,000

 

16.1 %

 

28,000

 

14.9 %

Asia Pacific Total

 

131,000

 

78.0 %

 

145,000

 

77.1 %

 

 

 

 

 

 

 

 

 

Americas and Europe

 

37,000

 

22.0 %

 

43,000

 

22.9 %

 

 

168,000

 

100.0 %

 

188,000

 

100.0 %

Direct Selling Active Preferred Customers by Region(2)

 

(unaudited)

 

 

As of

September 27, 2025

 

As of

September 28, 2024

Asia Pacific

 

 

 

 

 

 

 

 

Greater China

 

149,000

 

67.7 %

 

178,000

 

67.4 %

Southeast Asia Pacific

 

18,000

 

8.2 %

 

24,000

 

9.1 %

North Asia

 

10,000

 

4.6 %

 

13,000

 

4.9 %

Asia Pacific Total

 

177,000

 

80.5 %

 

215,000

 

81.4 %

 

 

 

 

 

 

 

 

 

Americas and Europe

 

43,000

 

19.5 %

 

49,000

 

18.6 %

 

 

220,000

 

100.0 %

 

264,000

 

100.0 %

______________________________

(1)

Brand Partners are independent distributors of our products who also purchase our products for their personal use. We only count as active those Brand Partners who have purchased from us any time during the most recent three-month period, either for personal use or resale.

(2)

Preferred Customers purchase our products strictly for their personal use and are not permitted to resell or to distribute the products. We only count as active those Preferred Customers who have purchased from us any time during the most recent three-month period. China utilizes a Preferred Customer program that has been implemented specifically for that market.

 

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

OPERATING RESULTS AS A PERCENTAGE OF NET SALES

(unaudited)

 

 

 

Quarter Ended

 

 

September 27, 2025

 

September 28, 2024

 

 

Direct selling & Other

 

Hiya direct-to-consumer

 

Consolidated

 

Direct selling & Other

 

Hiya direct-to-consumer

 

Consolidated

Net sales

 

100.0%

 

100.0%

 

100.0%

 

100.0%

 

N/A

 

100.0%

Cost of sales

 

20.7%

 

35.6%

 

22.8%

 

19.6%

 

N/A

 

19.6%

Gross profit

 

79.3%

 

64.4%

 

77.2%

 

80.4%

 

N/A

 

80.4%

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Brand Partner incentives

 

42.5%

 

—%

 

36.4%

 

42.0%

 

N/A

 

42.0%

Selling, general and administrative

 

35.8%

 

66.5%

 

40.2%

 

30.6%

 

N/A

 

30.6%

Total operating expenses

 

78.3%

 

66.5%

 

76.6%

 

72.6%

 

N/A

 

72.6%

Earnings (loss) from operations

 

1.0%

 

(2.1)%

 

0.6%

 

7.8%

 

N/A

 

7.8%

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of acquired intangible assets

 

0.2%

 

14.5%

 

2.2%

 

0.1%

 

N/A

 

0.1%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended

 

 

September 27, 2025

 

September 28, 2024

 

 

Direct selling & Other

 

Hiya direct-to-consumer

 

Consolidated

 

Direct selling & Other

 

Hiya direct-to-consumer

 

Consolidated

Net sales

 

100.0%

 

100.0%

 

100.0%

 

100.0%

 

N/A

 

100.0%

Cost of sales

 

19.1%

 

36.7%

 

21.7%

 

19.1%

 

N/A

 

19.1%

Gross profit

 

80.9%

 

63.3%

 

78.3%

 

80.9%

 

N/A

 

80.9%

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Brand Partner incentives

 

42.7%

 

—%

 

36.4%

 

42.2%

 

N/A

 

42.2%

Selling, general and administrative

 

33.0%

 

60.8%

 

37.1%

 

29.6%

 

N/A

 

29.6%

Total operating expenses

 

75.7%

 

60.8%

 

73.5%

 

71.8%

 

N/A

 

71.8%

Earnings from operations

 

5.2%

 

2.5%

 

4.8%

 

9.1%

 

N/A

 

9.1%

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of acquired intangible assets

 

0.2%

 

13.1%

 

2.0%

 

0.2%

 

N/A

 

0.2%

 

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.95
-4.08 (-1.84%)
AAPL  258.45
-4.32 (-1.64%)
AMD  230.23
-7.80 (-3.28%)
BAC  51.10
-0.42 (-0.82%)
GOOG  252.53
+1.19 (0.47%)
META  733.41
+0.14 (0.02%)
MSFT  520.54
+2.88 (0.56%)
NVDA  180.28
-0.88 (-0.49%)
ORCL  272.66
-2.49 (-0.90%)
TSLA  438.97
-3.63 (-0.82%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.